Advanced search
Publication Cover
Epigenomics Volume 5, 2013 - Issue 4
Submit an article Journal homepage
323
Views
0
CrossRef citations to date
0
Altmetric
Review

The P53 Mirna Interactome and its Potential Role in the Cancer Clinic

Jonathan Krell4 Department of Oncology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, 1st Floor, E Wing, Fulham Palace Road, London, W6 8RF, UKCorrespondence[email protected]
,
Adam E Frampton2 HPB Surgical Unit, Department of Surgery & Cancer, Imperial College, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK
,
Teresa Colombo3 Department of Cellular Biotechnology & Haematology, La Sapienza University, Rome, Italy
,
Tamara MH Gall2 HPB Surgical Unit, Department of Surgery & Cancer, Imperial College, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK
,
Alex De Giorgio1 Division of Oncology, Department of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus, Imperial Centre for Translational & Experimental Medicine, Du Cane Road, London, W12 0NN, UK
,
Victoria Harding1 Division of Oncology, Department of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus, Imperial Centre for Translational & Experimental Medicine, Du Cane Road, London, W12 0NN, UK
,
Justin Stebbing4 Department of Oncology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, 1st Floor, E Wing, Fulham Palace Road, London, W6 8RF, UK
&
Leandro Castellano1 Division of Oncology, Department of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus, Imperial Centre for Translational & Experimental Medicine, Du Cane Road, London, W12 0NN, UK
 show all
Pages 417-428 | Published online: 29 Jul 2013

References

  • Vaseva AV , MarchenkoND, JiK, TsirkaSE, HolzmannS, MollUM. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell149(7) , 1536–1548 (2012).
  • Sionov RV , HauptY. The cellular response to p53: the decision between life and death. Oncogene18(45) , 6145–6157 (1999).
  • Levine AJ . p53, the cellular gatekeeper for growth and division. Cell88(3) , 323–331 (1997).
  • Freedman DA , LevineAJ. Regulation of the p53 protein by the MDM2 oncoprotein – thirty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res.59(1) , 1–7 (1999).
  • Banin S , MoyalL, ShiehS et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281(5383) , 1674–1677 (1998).
  • An WG , KanekalM, SimonMC, MaltepeE, BlagosklonnyMV, NeckersLM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature392(6674) , 405–408 (1998).
  • Leung AK , SharpPA. microRNAs: a safeguard against turmoil? Cell130(4) , 581–585 (2007).
  • Chang TC , WentzelEA, KentOA et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26(5) , 745–752 (2007).
  • He L , HeX, LimLP et al. A microRNA component of the p53 tumour suppressor network. Nature 447(7148) , 1130–1134 (2007).
  • Sachdeva M , ZhuS, WuF et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl Acad. Sci. USA 106(9) , 3207–3212 (2009).
  • Yan HL , XueG, MeiQ et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 28(18) , 2719–2732 (2009).
  • Hermeking H . MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer12(9) , 613–626 (2012).
  • Suzuki HI , YamagataK, SugimotoK, IwamotoT, KatoS, MiyazonoK. Modulation of microRNA processing by p53. Nature460(7254) , 529–533 (2009).
  • Mudhasani R , ZhuZ, HutvagnerG et al. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J. Cell Biol. 181(7) , 1055–1063 (2008).
  • Hu W , ChanCS, WuR et al. Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol. Cell 38(5) , 689–699 (2010).
  • Le MT , TehC, Shyh-ChangN et al. MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23(7) , 862–876 (2009).
  • Yamakuchi M , FerlitoM, LowensteinCJ. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. USA105(36) , 13421–13426 (2008).
  • Fornari F , GramantieriL, GiovanniniC et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 69(14) , 5761–5767 (2009).
  • Nishida N , YokoboriT, MimoriK et al. MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int. J. Oncol. 38(5) , 1437–1443 (2011).
  • Kumar M , LuZ, TakwiAA et al. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 30(7) , 843–853 (2011).
  • Corney DC , Flesken-NikitinA, GodwinAK, WangW, NikitinAY. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res.67(18) , 8433–8438 (2007).
  • Raver-Shapira N , MarcianoE, MeiriE et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26(5) , 731–743 (2007).
  • Tarasov V , JungP, VerdoodtB et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6(13) , 1586–1593 (2007).
  • Siemens H , JackstadtR, HuntenS et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial–mesenchymal transitions. Cell Cycle 10(24) , 4256–4271 (2011).
  • Kaller M , LiffersST, OeljeklausS et al. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol. Cell. Proteomics 10(8) , M111.010462 (2011).
  • Heinemann A , ZhaoF, PechlivanisS et al. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res. 72(2) , 460–471 (2012).
  • Bommer GT , GerinI, FengY et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17(15) , 1298–1307 (2007).
  • Musumeci M , CoppolaV, AddarioA et al. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 30(41) , 4231–4242 (2011).
  • Yamakuchi M , LottermanCD, BaoC et al. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc. Natl Acad. Sci. USA 107(14) , 6334–6339 (2010).
  • Zhang J , SunQ, ZhangZ, GeS, HanZG, ChenWT. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2–p53 feedback loop. Oncogene (2012).
  • Yan D , DongXD, ChenX et al. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS One 7(7) , e40967 (2012).
  • Pichiorri F , SuhSS, RocciA et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18(4) , 367–381 (2010).
  • Wellner U , SchubertJ, BurkUC et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11(12) , 1487–1495 (2009).
  • Kim T , VeroneseA, PichiorriF et al. p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J. Exp. Med. 208(5) , 875–883 (2011).
  • Fabbri M , BottoniA, ShimizuM et al. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 305(1) , 59–67 (2011).
  • Ofir M , HacohenD, GinsbergD. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol. Cell. Proteomics9(4) , 440–447 (2011).
  • Bandi N , VassellaE. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol. Cancer10 , 55 (2011).
  • Klein U , LiaM, CrespoM et al. The DLEU2/miR-15a/16–11 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17(1) , 28–40 (2010).
  • Bhattacharya R , NicolosoM, ArvizoR et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 69(23) , 9090–9095 (2009).
  • Calin GA , DumitruCD, ShimizuM et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99(24) , 15524–15529 (2002).
  • Bonci D , CoppolaV, MusumeciM et al. The miR-15a–miR-16–11 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 14(11) , 1271–1277 (2008).
  • Gregory PA , BertAG, PatersonEL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10(5) , 593–601 (2008).
  • Bohlig L , FriedrichM, EngelandK. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res.39(2) , 440–453 (2011).
  • Zhu H , DoughertyU, RobinsonV et al. EGFR signals downregulate tumor suppressors miR-143 and miR-145 in western diet-promoted murine colon cancer: role of G1 regulators. Mol. Cell. Proteomics 9(7) , 960–975 (2011).
  • Xu N , PapagiannakopoulosT, PanG, ThomsonJA, KosikKS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell137(4) , 647–658 (2009).
  • Saleh AD , SavageJE, CaoL et al. Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One 6(10) , e24429 (2011).
  • Sundaram P , HultineS, SmithLM et al. p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Res. 71(24) , 7490–7501 (2011).
  • Jin L , HuWL, JiangCC et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc. Natl Acad. Sci. USA 108(38) , 15840–15845 (2011).
  • Feng Z , ZhangC, WuR, HuW. Tumor suppressor p53 meets microRNAs. J. Mol. Cell. Biol.3(1) , 44–50 (2011).
  • Boominathan L . The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One5(5) , e10615 (2010).
  • Pellegrino L , JacobJ, Roca-AlonsoL, KrellJ, CastellanoL, FramptonAE. Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers. Expert Rev. Anticancer Ther.13(1) , 21–27 (2013).
  • Kumar MS , PesterRE, ChenCY et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23(23) , 2700–2704 (2009).
  • Leveille N , ElkonR, DavalosV et al. Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity. Nat. Commun. 2 , 513 (2011).
  • Le MT , Shyh-ChangN, KhawSL et al. Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet. 7(9) , e1002242 (2011).
  • Herrera-Merchan A , CerratoC, LuengoG et al. miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 9(16) , 3277–3285 (2010).
  • Swarbrick A , WoodsSL, ShawA et al. miR-380–5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat. Med. 16(10) , 1134–1140 (2010).
  • Tian S , HuangS, WuS, GuoW, LiJ, HeX. MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3´ untranslated region. Biochem. Biophys. Res. Commun.396(2) , 435–439 (2010).
  • Yamakuchi M , LowensteinCJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle8(5) , 712–715 (2009).
  • Xiao J , LinH, LuoX, WangZ. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J.30(3) , 524–532 (2011).
  • Garibaldi F , CicchiniC, ConigliaroA et al. An epistatic mini-circuitry between the transcription factors Snail and HNF4alpha controls liver stem cell and hepatocyte features exhorting opposite regulation on stemness-inhibiting microRNAs. Cell Death Differ. 19(6) , 937–946 (2012).
  • Ahn YH , GibbonsDL, ChakravartiD et al. ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J. Clin. Invest. 122(9) , 3170–3183 (2012).
  • Milo R , Shen-OrrS, ItzkovitzS, KashtanN, ChklovskiiD, AlonU. Network motifs: simple building blocks of complex networks. Science298(5594) , 824–827 (2002).
  • Ragimov N , KrauskopfA, NavotN, RotterV, OrenM, AloniY. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene8(5) , 1183–1193 (1993).
  • Bousquet M , QuelenC, RosatiR et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J. Exp. Med. 205(11) , 2499–2506 (2008).
  • Zhou M , LiuZ, ZhaoY et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J. Biol. Chem. 285(28) , 21496–21507 (2010).
  • Shi XB , XueL, YangJ et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc. Natl Acad. Sci. USA 104(50) , 19983–19988 (2007).
  • Shi L , ZhangJ, PanT et al. MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation. Brain Res. 1312 , 120–126 (2010).
  • Hofmann MH , HeinrichJ, RadziwillG, MoellingK. A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells. Mol. Cell. Proteomics7(10) , 1635–1644 (2009).
  • Wu CI , ShenY, TangT. Evolution under canalization and the dual roles of microRNAs: a hypothesis. Genome Res.19(5) , 734–743 (2009).
  • Wagner A . Circuit topology and the evolution of robustness in two-gene circadian oscillators. Proc. Natl Acad. Sci. USA102(33) , 11775–11780 (2005).
  • Concepcion CP , HanYC, MuP et al. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet. 8(7) , e1002797 (2012).
  • Kasinski AL , SlackFJ. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res.72(21) , 5576–5587 (2012).
  • John B , EnrightAJ, AravinA, TuschlT, SanderC, MarksDS. Human microRNA targets. PLoS Biol.2(11) , e363 (2004).
  • Lewis BP , BurgeCB, BartelDP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell120(1) , 15–20 (2005).
  • Robins H , PressWH. Human microRNAs target a functionally distinct population of genes with AT-rich 3´ UTRs. Proc. Natl Acad. Sci. USA102(43) , 15557–15562 (2005).
  • Krell J , FramptonAE, StebbingJ. MicroRNAs in the cancer clinic. Front. Biosci. (Elite Ed.)5 , 204–213 (2013).
  • Trang P , WigginsJF, DaigeCL et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol. Ther. 19(6) , 1116–1122 (2011).
  • Kim HR , RoeJS, LeeJE, HwangIY, ChoEJ, YounHD. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH. Biochem. Biophys. Res. Commun.418(4) , 682–688 (2012).
  • Kim NH , KimHS, LiXY et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition. J. Cell Biol. 195(3) , 417–433 (2011).
  • Kim NH , KimHS, KimNG et al. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci. Signal. 4(197) , ra71 (2011).
  • Wu J , WuG, LvL et al. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 33(3) , 519–528 (2012).
  • Yamamura S , SainiS, MajidS et al. MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells. PLoS One 7(1) , e29722 (2012).
  • Liu Q , FuH, SunF et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 36(16) , 5391–5404 (2008).
  • Manfe V , BiskupE, RosbjergA et al. miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. PLoS One 7(1) , e29541 (2012).
  • Suh SO , ChenY, ZamanMS et al. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 32(5) , 772–778 (2011).
  • Wang J , LiJ, ShenJ, WangC, YangL, ZhangX. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer12 , 227 (2012).
  • Georges SA , BieryMC, KimSY et al. Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res. 68(24) , 10105–10112 (2008).
  • Song B , WangY, KudoK, GavinEJ, XiY, JuJ. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53–microRNA circuit. Clin. Cancer Res.14(24) , 8080–8086 (2008).
  • Shimono Y , ZabalaM, ChoRW et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138(3) , 592–603 (2009).
  • Choi YC , YoonS, JeongY, YoonJ, BaekK. Regulation of vascular endothelial growth factor signaling by miR-200b. Mol. Cells32(1) , 77–82 (2011).
  • Roybal JD , ZangY, AhnYH et al. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol. Cell. Proteomics 9(1) , 25–35 (2011).
  • Piovan C , PalmieriD, Di Leva G et al. Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol. Oncol.6(4) , 458–472 (2012).
  • Xiao J , LinH, LuoX, WangZ. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J.30(24) , 5021 (2011).
  • Barsotti AM , BeckermanR, LaptenkoO, HuppiK, CaplenNJ, PrivesC. p53-dependent induction of PVT1 and miR-1204. J. Biol. Chem.287(4) , 2509–2519 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.